News

Filter

Current filters:

FolviteDermatologicals

1 to 9 of 97209 results

Pfizer touts strong Ph III results for Lyrica CR for postherpetic neuralgia

19-12-2014

US pharma giant Pfizer has released top-line results from a double-blind Phase III study evaluating pregabalin…

LyricaNeurologicalPfizerPharmaceuticalPregabalinResearch

Gilead and Ono enter into a licensing agreement for ONO-4059

Gilead and Ono enter into a licensing agreement for ONO-4059

19-12-2014

Japanese pharma company Ono Pharmaceutical and US biotech major Gilead Sciences have entered into a licensing…

BiotechnologyGilead SciencesLicensingOncologyOno PharmaceuticalONO-4059Research

PhRMA releases new report on challenges to developing new hepatitis C treatments

PhRMA releases new report on challenges to developing new hepatitis C treatments

19-12-2014

The Pharmaceutical Research and Manufacturers of America released a new report examining the scientific…

Manufacturers of AmericaPharmaceuticalPhRMAResearchRespiratory and Pulmonary

Sorrento and Conkwest join forces on cancer immunotherapies development

19-12-2014

US cancer drug developer Sorrento Therapeutic and privately-held Conkwest have entered into a definitive…

BiotechnologyConkwestFinancialNeukoplastOncologyResearchSorrento Therapeutics

Polaris Group receives orphan drug designation for ADI-PEG 20 from the FDA

Polaris Group receives orphan drug designation for ADI-PEG 20 from the FDA

19-12-2014

Privately-held Polaris Group has received orphan drug designation for ADI-PEG 20 (pegylated arginine…

ADI-PEG 20OncologyPharmaceuticalPolaris GroupRegulation

Cardinal Health and Bayer sign 15-year contract manufacturing agreement for Xofigo

Cardinal Health and Bayer sign 15-year contract manufacturing agreement for Xofigo

19-12-2014

Cardinal Health and German drug major Bayer have signed a 15-year agreement for the contract manufacturing…

BayerCardinal HealthLicensingOncologyPharmaceuticalProductionUSAXofigo

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

1 to 9 of 97209 results

Back to top